Literature DB >> 22342051

Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.

Sabahattin Altunyurt1, Emre Okyay, Bahadir Saatli, Turab Canbahishov, Namik Demir, Hasan Ozkan.   

Abstract

OBJECTIVE: To evaluate neonatal outcomes among a homogeneous group of fetuses with severe hydrops treated with intrauterine transfusion (IUT).
METHODS: In a prospective study at Dokuz Eylul University School of Medicine, Izmir, Turkey, outcomes were compared for 35 IUTs carried out between 2005 and 2010 in 19 pregnancies that were complicated by Rhesus D hemolytic disease with severely hydropic fetuses.
RESULTS: There was no correlation between the number of IUTs and the duration of phototherapy or number of exchange transfusions. After delivery, 36% (7/19) of neonates tested positive in a direct Coombs test and their requirement for exchange transfusion was higher than that of neonates who tested negative. The neonatal survival rate was 73.7%. Admission to the neonatal intensive care unit was 78%, and the median duration of neonatal unit stay was 4 days (range, 1-77 days). Only 1 newborn had hearing impairment.
CONCLUSION: IUT is a unique, gold standard treatment for severely hydropic fetuses. When treated optimally with IUT, fetuses with severe hydrops showed no increased risk of neurodevelopmental abnormalities. Factors affecting the survival of hydropic fetuses after IUT, and whether the number of IUTs performed affects the number of exchange transfusions required remain unclear.
Copyright © 2012 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342051     DOI: 10.1016/j.ijgo.2011.12.013

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  4 in total

Review 1.  Recommendations for transfusion therapy in neonatology.

Authors:  Gabriella Girelli; Stefano Antoncecchi; Anna Maria Casadei; Antonio Del Vecchio; Paola Isernia; Mario Motta; Daniela Regoli; Costantino Romagnoli; Gino Tripodi; Claudio Velati
Journal:  Blood Transfus       Date:  2015-07       Impact factor: 3.443

2.  Combination peptide immunotherapy suppresses antibody and helper T-cell responses to the RhD protein in HLA-transgenic mice.

Authors:  Lindsay S Hall; Andrew M Hall; Wendy Pickford; Mark A Vickers; Stanislaw J Urbaniak; Robert N Barker
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

3.  Perinatal Outcome After Intrauterine Transfusion in Rh Isoimmunized Mothers.

Authors:  Omkar Potdar; Hemraj R Narkhede; Purnima R Satoskar
Journal:  J Obstet Gynaecol India       Date:  2018-04-02

4.  Different Types of Minor Blood Group Incompatibility Causing Haemolytic Disease of Neonates in one of the National Children's Medical Centre in China.

Authors:  Mingchun Lin; Meixiu Liu; Shulian Zhang; Chao Chen; Jin Wang
Journal:  J Blood Med       Date:  2021-06-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.